Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Bal Pharma Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

BAL PHARMA LIMITED

www.balpharma.com

All Companies ›

Karnataka ›

Health and Social Work ›

BAL PHARMA LIMITED

Active

Updated: 17 Aug 2026

The company manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

Bal Pharma Limited, is a listed public company incorporated on 19 May, 1987. It is classified as a public limited company and is located in Bangalore South, Karnataka. It's authorized share capital is INR 24.50 cr and the total paid-up capital is INR 15.92 cr.

Subscription Plans

Industry and products

Health and Social Work

Intravenous Infusion Products, Generics, Women's Health Products, Prescription Drugs, Bulk Actives

Company size

Auth Capital

₹ 24.5 Cr

Paidup Capital

₹ 15.9 Cr

Revenue

₹ 300-400 cr

Key Metrics

** All rupee values in INR crores.

Total Revenue

-10.89%

₹ GET PRO

EBITDA

-7.29%

₹ GET PRO

Net Profit

-24.07%

₹ GET PRO

Networth

-6.4%

₹ GET PRO

Borrowings

8.06%

₹ GET PRO

Assets

-2.97%

₹ GET PRO

Gross Margin

4.48

GET PRO %

Operating Margin

0.36

GET PRO %

Net Profit Margin

-0.44

GET PRO %

Return on Equity

-1.84

GET PRO %

ROCE

-1.0

GET PRO %

Debt to Equity

0.19

GET PRO

Sales

Mar 2025

Net worth

Mar 2025

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (16)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Jatish Sheth	00581963	5 years
Director	Nicola Neeladri	01997936	3 years
Director	Rengarajan Gopalakrishnan	07587488	7 years
Whole-time director	Chittanand Damodar Kotian Shareholder	09613054	4 years
Managing Director	Shailesh Siroya Shareholder	00048109	22 years
Deputy Nodal Officer	Virupakshaya Himesh	08554422	6 years
Director	H S Venkatesh	01776040	6 years
Director	Ravindrakumar Kothari	03418320	1 years

Financial Highlights

Financials upto March 2025 available in Tofler Pro

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2025 available in Tofler Pro

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	14.8	14.8	15.7	15.8	15.9
Reserves	38.5	43.7	48.0	53.5	61.5
Borrowings +	104.8	97.8	131.0	139.6	150.4
Long term borrowings	23.9	27.0	30.5	36.3	31.4
Short term borrowings	80.8	70.7	100.5	103.2	119.0
Trade payables +	47.2	65.6	88.1	86.8	81.7
Days payable	114.0	143.0	186.0	165.0	189.0
Other liabilities +	34.8	38.8	30.3	23.8	26.2
Other non-current liabilities	10.3	9.5	9.6	10.9	7.4
Other current liabilities	24.5	29.3	20.7	13.0	18.8
Total liabilities	240.1	260.6	313.2	319.5	335.7
Fixed Assets +	68.6	69.1	76.5	77.3	89.6
Tangible assets	57.5	55.7	62.2	61.6	71.0
CWIP	-	1.6	-	0.5	2.8
Intangible assets	11.1	11.8	14.3	15.2	15.8
LT loans and advances	0.4	0.4	-	0.1	-
Other non-current assets	7.0	6.6	8.5	8.0	11.2
Current assets +	164.1	184.6	228.2	234.1	234.9
Inventories	60.4	74.4	98.0	87.8	103.0
Trade receivables	67.2	75.3	94.0	99.6	92.4
Cash and cash equivalents	1.0	1.1	1.5	4.2	1.8
ST loans and advances	2.1	2.4	1.0	1.4	1.1
Other current assets	33.5	31.4	33.7	41.1	36.5
Total assets	240.1	260.6	313.2	319.5	335.7

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.17	5.69	5.01	4.95	4.74
Reserves	16.05	16.76	15.33	16.73	18.32
Borrowings +	43.63	37.51	41.83	43.69	44.8
Long term borrowings	9.97	10.36	9.75	11.38	9.35
Short term borrowings	33.66	27.15	32.08	32.31	35.44
Trade payables	19.65	25.16	28.14	27.17	24.33
Other liabilities +	14.5	14.89	9.69	7.46	7.81
Other non-current liabilities	4.27	3.63	3.07	3.4	2.2
Other current liabilities	10.22	11.25	6.62	4.06	5.61
Total liabilities
Fixed Assets +	28.57	26.51	24.42	24.19	26.69
Tangible assets	23.95	21.36	19.85	19.28	21.15
CWIP	0.0	0.62	0.0	0.15	0.83
Intangible assets	4.61	4.54	4.56	4.76	4.71
LT loans and advances	0.16	0.15	0.03	0.04	0.0
Other non-current assets	2.9	2.52	2.7	2.5	3.34
Current assets +	68.37	70.82	72.85	73.28	69.97
Inventories	25.15	28.55	31.29	27.48	30.69
Trade receivables	27.99	28.9	30.01	31.18	27.54
Cash and cash equivalents	0.43	0.43	0.47	1.31	0.52
ST loans and advances	0.86	0.91	0.31	0.43	0.34
Other current assets	13.94	12.04	10.77	12.88	10.88
Total assets

Total assets

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
NOVOSYNTH RESEARCH LABS PRIVATE LIMITED	Strike Off	3.5 L	1	Karnataka
SANJAY GEMS PVT LTD	Strike Off	1.1 L	1	Maharashtra
LEGEND SIROYA INFRASTRUCTURE PRIVATE LIMITED	Strike Off	1.0 L	1	Maharashtra
KAUNSHYA INVESTMENTS PRIVATE LIMITED	Active	81.0 L	1	Karnataka
SIROYA PROPERTIES & HOLDINGS PRIVATE LIMITED	Under Process of Striking Off	1.0 L	1	Karnataka
SIROYA BUILDERS & REAL ESTATES PRIVATE LIMITED	Under Process of Striking Off	1.0 L	1	Karnataka
BASAV CHEM LIMITED	Amalgamated	10.0 L	1	Karnataka
AURUM RESEARCH & ANALYTICAL SOLUTIONS PRIVATE LIMITED	Active	1.0 L	2	Karnataka
GROW INDIA FINANCIAL ADVISORS LLP	Strike Off	1.0 L	1	Karnataka
BALANCE CLINICS LLP	Active	10.0 L	2	Karnataka
GOLDEN DRUGS PRIVATE LIMITED	Active	3.6 Cr	2	Karnataka
LIFEZEN HEALTHCARE PRIVATE LIMITED	Active	2.0 Cr	2	Karnataka
BAL RESEARCH FOUNDATION	Active	10.0 L	2	Karnataka
MEGANZA PHARMA LLP	Active	50,000.0	1	Karnataka
SRUSHTI PHARMACEUTICALS PRIVATE LIMITED	Active	6.8 L	1	Karnataka
UMIYA BUILDCON LIMITED	Active	9.3 Cr	2	Karnataka
KUTUMBADAILY PRIVATE LIMITED	Active	1.0 L	1	Karnataka
WILDCRAFT INDIA LIMITED	Active	55.7 Cr	1	Karnataka
RED SUN DIAMONDS IMPEX PRIVATE LIMITED	Strike Off	1.0 L	1	Karnataka
RED SUN INFORMATION TECHNOLOGIES PRIVATE LIMITED	Active	1.0 L	1	Karnataka
LIFE SCIENCE TECH KVALITO INDIA PRIVATE LIMITED	Active	1.0 L	1
ISG NOVASOFT TECHNOLOGIES LIMITED	Active	6.7 Cr	1	Karnataka
SAI SHIVANI MANAGEMENT ADVISORY SERVICES LLP	Active	1.0 L	1	Karnataka

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
LIFEZEN HEALTHCARE PRIVATE LIMITED	Karnataka	2014	₹ 2.0 Cr
AURUM RESEARCH & ANALYTICAL SOLUTIONS PRIVATE LIMITED	Karnataka	2023	₹ 1.0 L
BAL RESEARCH FOUNDATION	Karnataka	2014	₹ 10.0 L

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

L85110KA1987PLC008368

Incorporation

1987, 39.3 years

Company Email

XYZVENUMADHAV@YAHOO.COM

Paid up Capital

₹ 15.9 Cr

Authorised Capital

₹ 24.5 Cr

AGM

Sep 2025

Type

Public

Others

FAQ - BAL PHARMA LIMITED

What is the incorporation date of BAL PHARMA LIMITED?

The incorporation date of BAL PHARMA LIMITED is 19 May, 1987

What is the authorized share capital of BAL PHARMA LIMITED?

The authorized share capital of BAL PHARMA LIMITED is INR ₹ 24.5 Cr.

What is the paid-up capital of BAL PHARMA LIMITED?

The paid-up capital of BAL PHARMA LIMITED is INR ₹ 15.9 Cr.

What is the registered address of BAL PHARMA LIMITED?

The registered address of BAL PHARMA LIMITED is 21-22, BOMMASANDRA INDUSTRIAL AREA Bangalore South Karnataka - 560099

What is the CIN number of BAL PHARMA LIMITED?

The CIN number of BAL PHARMA LIMITED is L85110KA1987PLC008368.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

BAL PHARMA LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Company Network